MRI Detection of Microbleeds in Glioma Patients

Overview

Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.

Full Title of Study: “Detection of Microbleeds With MRI (SWI Sequences) in Glioma Patients”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: August 2015

Clinical Trial Outcome Measures

Primary Measures

  • Number of microbleeds diagnosed with MRI (susceptibility weighted imaging sequence)
    • Time Frame: At the time of each MRI conducted within 5 years after diagnosis

Participating in This Clinical Trial

Inclusion Criteria

  • Adult patients – Diagnosed with brain glioblastoma – Receiving treatment with cranial radiotherapy and/or chemotherapy – Having at least one follow-up MRI conducted that used a susceptibility weighted imaging sequence Exclusion Criteria:

  • Underage – Absence of formal diagnosis of glioblastoma – No available medical imaging file with MRI susceptibility weighted imaging sequence

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fondation Ophtalmologique Adolphe de Rothschild
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.